Process View
The chemical reactions and pathways involving of any of a diverse group of vitamins that are soluble in organic solvents and relatively insoluble in water.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "fat soluble vitamin metabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 1.000 | Human | |
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 1.000 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.999 | Human | |
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.993 | Human | |
| IL1R1 | interleukin 1 receptor, type I | 0.987 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.973 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.968 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.961 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.952 | ||
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.878 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.840 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.799 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.675 | ||
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.545 | Human | |
| TNIP1 | TNFAIP3 interacting protein 1 | 0.476 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.430 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.395 | ||
| JUB | jub, ajuba homolog (Xenopus laevis) | 0.358 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.339 | ||
| HR | hairless homolog (mouse) | 0.328 | ||
| RXRA | retinoid X receptor, alpha | 0.255 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.205 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.171 | ||
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.171 | ||
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.148 | ||
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.125 | Human | |
| NOTCH1 | notch 1 | 0.108 | ||
| JAG2 | jagged 2 | 0.080 | ||
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.073 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.072 | ||
| RUNDC3A | RUN domain containing 3A | 0.072 | ||
| NELL2 | NEL-like 2 (chicken) | 0.070 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.064 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.058 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.052 | ||
| SMAD9 | SMAD family member 9 | 0.052 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.048 | Human | |
| TRAF2 | TNF receptor-associated factor 2 | 0.046 | ||
| CYP3A5 | cytochrome P450, family 3, subfamily A, polypeptide 5 | 0.046 | Human | |
| ATN1 | atrophin 1 | 0.044 | ||
| BEND5 | BEN domain containing 5 | 0.040 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.033 | Human | |
| CXXC5 | CXXC finger protein 5 | 0.033 | ||
| CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 | 0.031 | Human | |
| CCL20 | chemokine (C-C motif) ligand 20 | 0.029 | ||
| RAB35 | RAB35, member RAS oncogene family | 0.028 | ||
| ZNRF3 | zinc and ring finger 3 | 0.026 | ||
| BTRC | beta-transducin repeat containing | 0.026 | ||
| PDZD4 | PDZ domain containing 4 | 0.026 | ||
| CD81 | CD81 molecule | 0.025 | ||
| PRDX4 | peroxiredoxin 4 | 0.023 | ||
| DAO | D-amino-acid oxidase | 0.023 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.022 | ||
| C8A | complement component 8, alpha polypeptide | 0.022 | ||
| CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.022 | ||
| HAL | histidine ammonia-lyase | 0.022 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.020 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.020 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.020 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.020 | ||
| XDH | xanthine dehydrogenase | 0.019 | ||
| ANKS3 | ankyrin repeat and sterile alpha motif domain containing 3 | 0.019 | ||
| MAT1A | methionine adenosyltransferase I, alpha | 0.019 | ||
| PLOD1 | procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1 | 0.019 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.018 | ||
| SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.018 | ||
| AQP9 | aquaporin 9 | 0.018 | ||
| USHBP1 | Usher syndrome 1C binding protein 1 | 0.017 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.017 | ||
| ATXN7 | ataxin 7 | 0.016 | ||
| IL1A | interleukin 1, alpha | 0.016 | Human | |
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.016 | ||
| MYH14 | myosin, heavy chain 14, non-muscle | 0.016 | ||
| ARG1 | arginase, liver | 0.016 | ||
| PAH | phenylalanine hydroxylase | 0.016 | ||
| CYP4F11 | cytochrome P450, family 4, subfamily F, polypeptide 11 | 0.015 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.015 | ||
| TSPAN4 | tetraspanin 4 | 0.015 | ||
| MON1A | MON1 homolog A (yeast) | 0.015 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.015 | ||
| CD83 | CD83 molecule | 0.015 | ||
| KALRN | kalirin, RhoGEF kinase | 0.015 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.015 | Human | |
| RNF31 | ring finger protein 31 | 0.014 | ||
| KNG1 | kininogen 1 | 0.014 | ||
| RUNX1 | runt-related transcription factor 1 | 0.014 | ||
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.014 | ||
| RABAC1 | Rab acceptor 1 (prenylated) | 0.013 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.013 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.013 | ||
| RARA | retinoic acid receptor, alpha | 0.013 | ||
| CEACAM7 | carcinoembryonic antigen-related cell adhesion molecule 7 | 0.013 | ||
| ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | 0.012 | ||
| SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.012 | ||
| MCM3AP | minichromosome maintenance complex component 3 associated protein | 0.012 | ||
| SULT1B1 | sulfotransferase family, cytosolic, 1B, member 1 | 0.012 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.012 | ||
| CHUK | conserved helix-loop-helix ubiquitous kinase | 0.012 | ||
| TXNDC11 | thioredoxin domain containing 11 | 0.012 | ||
| PRDM5 | PR domain containing 5 | 0.012 | ||
| MED25 | mediator complex subunit 25 | 0.012 | ||
| IVL | involucrin | 0.012 | ||
| VSNL1 | visinin-like 1 | 0.012 | ||
| YIF1A | Yip1 interacting factor homolog A (S. cerevisiae) | 0.012 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.012 | ||
| TNF | tumor necrosis factor | 0.011 | ||
| CA5A | carbonic anhydrase VA, mitochondrial | 0.011 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.011 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.011 | ||
| RAB11FIP4 | RAB11 family interacting protein 4 (class II) | 0.011 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.011 | ||
| EGR1 | early growth response 1 | 0.011 | ||
| PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 0.011 | ||
| EGFL7 | EGF-like-domain, multiple 7 | 0.011 | ||
| GPR12 | G protein-coupled receptor 12 | 0.010 | ||
| AZGP1 | alpha-2-glycoprotein 1, zinc-binding | 0.010 | ||
| CD63 | CD63 molecule | 0.010 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.010 | ||
| F9 | coagulation factor IX | 0.010 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.010 | ||
| CYP4A22 | cytochrome P450, family 4, subfamily A, polypeptide 22 | 0.010 | Human |